Camber Capital Management LP 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 08:32 am Sale | 2024-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 3,100,000 3.410% | -4,535,000 (-59.40%) | Filing |
| 2024-02-14 08:24 am Purchase | 2023-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 7,635,000 8.500% | 635,000 (+9.07%) | Filing |
| 2023-02-14 08:46 am Purchase | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 7,000,000 8.640% | 2,300,000 (+48.94%) | Filing |
| 2022-05-12 4:06 pm Purchase | 2022-05-02 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 4,700,000 5.850% | 1,950,000 (+70.91%) | Filing |
| 2022-02-14 09:39 am Sale | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 2,750,000 3.440% | -2,250,000 (-45.00%) | Filing |
| 2021-02-16 08:20 am Purchase | 2020-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 5,000,000 6.650% | 1,000,000 (+25.00%) | Filing |
| 2020-06-22 10:01 am Purchase | 2020-06-11 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 4,000,000 5.370% | 2,500,000 (+166.67%) | Filing |